Geriatria
Nova diretriz do CDC afirma que as vacinas contra influenza e Covid podem ser administradas juntas – “Vacinas contra COVID-19 e outras vacinas agora podem ser administradas sem preocupações quanto ao intervalo entre elas.”
30 Ago, 2021 | 13:33hConteúdo relacionado: Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States – Centers for Disease Control and Prevention
Comentário: Flu shot and a COVID jab? New 2021-2022 flu vaccine guidance points to both – McKnight’s
#ESCCongress | Estudo randomizado: inibição de SGLT2 reduziu o risco combinado de morte cardiovascular ou hospitalização em pacientes com insuficiência cardíaca e fração de ejeção preservada, independentemente da presença ou ausência de diabetes.
30 Ago, 2021 | 13:21hEmpagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine
Comunicado de imprensa: Trial reports first successful results for heart failure with preserved ejection fraction – European Society of Cardiology
Comentário no Twitter
#FIGARO-DKD #ESCCongress
🔺in patients w T2D & microalbuminuria & stage 1-4 CKD, finerenone vs placebo led to 13% relative ⬇️in CV events (mostly due to 29%⬇️in HF hospitalizations)
🔺~2/3 pts +microalbuminuria w normal GFR:🔑 is to✔️in T2D#ESCCongress https://t.co/8oT5s8KjT0 pic.twitter.com/fQbmUzPasD— Ritu Thamman MD (@iamritu) August 28, 2021
#ESCCongress | Estudo randomizado mostrou discreto benefício do rastreamento sistemático para fibrilação atrial em idosos – Após um seguimento médio de 6,9 anos, houve menos eventos (AVC, embolia, sangramento e morte) no grupo intervenção (31,9%) vs. grupo controle (33%).
30 Ago, 2021 | 13:08hClinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial – The Lancet (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Screening for atrial fibrillation could reduce risk of stroke – Karolinska Institutet
Consenso multinacional sobre disfagia na doença de Parkinson: rastreamento, diagnóstico e valor prognóstico.
30 Ago, 2021 | 11:46hGuia OMS | Apoio para reabilitação: autocuidado após COVID-19.
26 Ago, 2021 | 12:51h
Comentário no Twitter
The World Health Organisation have just published: Support for rehabilitation: self-management after COVID-19-related illness, 2nd ed. Written by the Leeds Rehabilitation team. Accessed from https://t.co/Ep4KG2FTiQ Will be in all European languages soon.
— Derick Wade (@derickwaderehab) August 25, 2021
Novas diretrizes publicadas para auxiliar os médicos a lidar com pacientes com “long COVID”.
26 Ago, 2021 | 12:33hNew guidelines to help doctors manage long COVID patients published – Imperial College London
Artigo original: Recommendations for the recognition, diagnosis, and management of long covid: A Delphi study – British Journal of General Practice
Conteúdo relacionado: M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)
Diretrizes de consenso com recomendações para atividade física em idosos.
26 Ago, 2021 | 12:25hOrganizações de manutenção da saúde (health maintenance organizations – HMO) israelenses afirmam que a terceira dose da vacina da Pfizer tem 86% de efetividade em maiores de 60 anos.
25 Ago, 2021 | 13:20hThird Pfizer dose 86% effective in over 60s, Israeli HMO says – Reuters
Comentário no Twitter
A third dose of Pfizer (PFE.N)/BioNTech's (https://t.co/eeCVHZYuCn) COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from a study of thousands of members. https://t.co/BQMzYmMHUt
— Reuters Health (@Reuters_Health) August 18, 2021
Revisão | Hiponatremia aguda e crônica.
25 Ago, 2021 | 13:05hAcute and Chronic Hyponatremia – Frontiers in Medicine
Conteúdos relacionados:
Podcast: Hyponatremia deconstructed
Guidelines for the Management of Exercise-Associated Hyponatremia
Estudo randomizado | Inibidores de SGLT2 reduzem o risco de hiperpotassemia em pacientes com diabetes e doença renal crônica.
24 Ago, 2021 | 11:36hEffects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial – European Heart Journal (link para o resumo – $ para o texto completo)
Comentário no Twitter
SGLT2 inhibition reduces the risk of serious hyperkalemia in people with diabetic kidney disease, which may enable greater use of RAAS inhibitors in CKD and/or heart failure
New CREDENCE data presented this week at #ESCCongress, now in @ESC_Journals:https://t.co/OEqnXTdBDi pic.twitter.com/zsanEFZVCy
— Brendon Neuen (@brendonneuen) August 23, 2021